search
Back to results

Ondansetron's Opposite Effect on Postoperative Analgesia of Acetaminophen (OOEOPAOA)

Primary Purpose

Postoperative Pain

Status
Completed
Phase
Phase 4
Locations
Turkey
Study Type
Interventional
Intervention
ondansetron
isotonic
Sponsored by
Mustafa Kemal University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Postoperative Pain focused on measuring Acetaminophen, ondansetron

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients 18-80 years old scheduled for hysterectomy
  • Horizontal or vertical abdominal skin incision
  • Ability to operate a patient-controlled analgesia (PCA) device
  • Written informed consent.

Exclusion Criteria:

  • Emergency or urgent procedures
  • Women with pre-existing chronic pain at any site requiring opioid analgesia
  • Who had a history of significant Axis I psychiatric disease (major depressive disorder, bipolar disorder, schizophrenia, etc.)
  • Significant hepatic (alanine aminotransferase or aspartate aminotransferase >2 times normal) or renal (serum creatinine >2 mg/dl) impairment
  • Allergy to ondansetron or acetaminophen
  • Were pregnant

Sites / Locations

  • Mustafa Kemal University Medicine Faculty

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

ondansetron

isotonic

Arm Description

ondansetron iv, 8 mg, skin closure time

isotonic 2ml, once, skin closure time

Outcomes

Primary Outcome Measures

Postoperative pain
Visual analogue scale
Opioid (tramadol) consumption
Tramadol consumption

Secondary Outcome Measures

Postoperative complications

Full Information

First Posted
August 24, 2014
Last Updated
March 12, 2015
Sponsor
Mustafa Kemal University
search

1. Study Identification

Unique Protocol Identification Number
NCT02296333
Brief Title
Ondansetron's Opposite Effect on Postoperative Analgesia of Acetaminophen
Acronym
OOEOPAOA
Official Title
Double Blinded Study Ondansetron's Opposite Effect on Postoperative Analgesia of Acetaminophen
Study Type
Interventional

2. Study Status

Record Verification Date
March 2015
Overall Recruitment Status
Completed
Study Start Date
May 2014 (undefined)
Primary Completion Date
November 2014 (Actual)
Study Completion Date
December 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Mustafa Kemal University

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of the study is to determine whether the effect of ondansetron on the analgesic effect of acetaminophen. Because 5HT3 blockers prevent the analgesic effects of acetaminophen and also reduce opioid consumption
Detailed Description
The investigators enrolled 80 American Society of Anesthesiologists Physical Status I-II women 18-80 years old scheduled for hysterectomy under general anesthesia over the course of a year. The study will be restricted hysterectomies with horizontal abdominal skin incision who will be able to operate a patient-controlled analgesia (PCA) device. Participating women will be premedicated with 1-2 mg intravenous (IV) midazolam per preference of the attending anesthesiologist. Anesthesia will be induced with propofol (2 mg/kg IV); intubation will be facilitated by rocuronium (0.6 mg/kg IV); and anesthesia will be maintained by sevoflurane in combination with nitrous oxide 50% in oxygen. Fentanyl, 2 µg/kg intravenous will be given 3-5 min before the surgical incision. After endotracheal intubation, all patients' lungs will be mechanically ventilated to maintain the end-expiratory carbon dioxide values between 34 and 36 mmHg. A Pfannenstiel approach will be used in each woman, and the same surgeon will be conducted all operations. Randomization will be web-based and out of the control of any investigator. The web system will be accessed by the anesthesia resident at the induction. Drugs will be covered by opaque plastic to keep the surgical team and anesthesiologists blinded to treatment. Both groups patients will be received 1 g acetaminophen in 100 ml saline given every 6 hours starting with the skin closure for 24 hours, an amount generally regarded as safe. Group I patients will be received '8 mg ondansetron hydrochloride' Group II patients will be received '2 ml saline' Both of them will be applied in a 100 ml saline bag at the same time with the skin closure. After return of spontaneous ventilation and tracheal extubation, patients will be transferred to the post anesthesia care unit (PACU). Patients were connected to a patient-controlled analgesia (PCA) device and postoperative analgesia will be provided using 20-mg intravenous bolus injections of tramadol at a lockout interval of 15 min and with a maximum 4-h limit of 150 mg. The PCA device will be discontinued when the patient made no demands for the opioid analgesic in the preceding 4-h interval or at a maximum of 24 hours after surgery. heart rate systolic arterial blood pressures diastolic arterial blood pressures mean arterial blood pressures oxygen saturation respiratory rate visual analogue scales while sitting and laying tramadol consumption additive analgesics complications postoperative nausea and vomiting scores antiemetic use will be assessed at PACU, 1th. hour, 4th hour, 8th hour, 12th hour, 16th hour, 20th hour and 24th hour. Pain satisfaction scale ambulation time first flatus time oral intake time Hospital anxiety and depression scale When pain scores were VAS ≥5, then as a rescue analgesics 75 mg diclofenac Na intramuscularly will be given. If systolic arterial pressure (SAP) will be <90 mmHg or mean arterial pressure will be <50 mmHg, 5 mg intravenous ephedrine HCl will be given. If the heart rate will be <50 beats/minute, 0.5 mg atropine sulfate intravenous will be given. When patients sustained nausea or vomiting lasting longer than 5 minutes, metoclopramide (10 mg intravenously) will be given.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postoperative Pain
Keywords
Acetaminophen, ondansetron

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Care ProviderInvestigator
Allocation
Randomized
Enrollment
80 (Actual)

8. Arms, Groups, and Interventions

Arm Title
ondansetron
Arm Type
Active Comparator
Arm Description
ondansetron iv, 8 mg, skin closure time
Arm Title
isotonic
Arm Type
Placebo Comparator
Arm Description
isotonic 2ml, once, skin closure time
Intervention Type
Drug
Intervention Name(s)
ondansetron
Other Intervention Name(s)
Zofran
Intervention Description
8 mg intravenous in the skin closure
Intervention Type
Drug
Intervention Name(s)
isotonic
Intervention Description
8 mg intravenous in the skin closure
Primary Outcome Measure Information:
Title
Postoperative pain
Description
Visual analogue scale
Time Frame
Postoperative 24 hours
Title
Opioid (tramadol) consumption
Description
Tramadol consumption
Time Frame
Postoperative 24 hours
Secondary Outcome Measure Information:
Title
Postoperative complications
Time Frame
Postoperative 24 hours

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients 18-80 years old scheduled for hysterectomy Horizontal or vertical abdominal skin incision Ability to operate a patient-controlled analgesia (PCA) device Written informed consent. Exclusion Criteria: Emergency or urgent procedures Women with pre-existing chronic pain at any site requiring opioid analgesia Who had a history of significant Axis I psychiatric disease (major depressive disorder, bipolar disorder, schizophrenia, etc.) Significant hepatic (alanine aminotransferase or aspartate aminotransferase >2 times normal) or renal (serum creatinine >2 mg/dl) impairment Allergy to ondansetron or acetaminophen Were pregnant
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Onur Koyuncu, Ass.prof
Organizational Affiliation
Mustafa Kemal University Medicine Faculty
Official's Role
Study Chair
Facility Information:
Facility Name
Mustafa Kemal University Medicine Faculty
City
Hatay
ZIP/Postal Code
31030
Country
Turkey

12. IPD Sharing Statement

Citations:
PubMed Identifier
1904822
Citation
Tjolsen A, Lund A, Hole K. Antinociceptive effect of paracetamol in rats is partly dependent on spinal serotonergic systems. Eur J Pharmacol. 1991 Feb 7;193(2):193-201. doi: 10.1016/0014-2999(91)90036-p.
Results Reference
result
PubMed Identifier
16580905
Citation
Pickering G, Loriot MA, Libert F, Eschalier A, Beaune P, Dubray C. Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism. Clin Pharmacol Ther. 2006 Apr;79(4):371-8. doi: 10.1016/j.clpt.2005.12.307.
Results Reference
result
PubMed Identifier
20220746
Citation
Jokela R, Ahonen J, Seitsonen E, Marjakangas P, Korttila K. The influence of ondansetron on the analgesic effect of acetaminophen after laparoscopic hysterectomy. Clin Pharmacol Ther. 2010 Jun;87(6):672-8. doi: 10.1038/clpt.2009.281. Epub 2010 Mar 10.
Results Reference
result
Links:
URL
http://www.ncbi.nlm.nih.gov/pubmed/20220746
Description
http://www.ncbi.nlm.nih.gov/pubmed/20220746

Learn more about this trial

Ondansetron's Opposite Effect on Postoperative Analgesia of Acetaminophen

We'll reach out to this number within 24 hrs